Researchers advance CRISPR technology to replicate human diseases with unprecedented accuracy
by Walter and Eliza Hall Institute of Medical ResearchGeneration and validation of pdCas9a-SAM construct in Eµ-Myc lymphoma cell lines. a Schematic representation of the pdCas9a-SAM lentiviral co
Updated on: February 03,2024
Researchers advance CRISPR technology to replicate human diseases with unprecedented accuracy
by Walter and Eliza Hall Institute of Medical ResearchGeneration and validation of pdCas9a-SAM construct in Eµ-Myc lymphoma cell lines. a Schematic representation of the pdCas9a-SAM lentiviral co
Updated on:February 03,2024
